The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation

被引：0
作者：
Monika Biedroń
Justyna Rybka
Tomasz Wróbel
Iwona Prajs
Rafał Poręba
Kazimierz Kuliczkowski
机构：
[1] Wroclaw Medical University,Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation
[2] Wroclaw Medical University,Department of Internal Medicine
来源：
Medical Oncology | 2015年 / 32卷
关键词：
Human leukocyte antigen; Acute leukemia; Allogeneic stem cell transplantation; Graft-versus-host disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
HLA-G is a non-classical MHC class I molecule whose suppressive activity on immune effector cells is exerted due to interactions with receptors ILT2, ILT4 and KIR2DL4. These receptors are expressed mainly on NK cells and monocytes, and their intensity of expression changes depending on HLA-G level. HLA-G plays an important role in the development of tolerance following organ transplantations and bone marrow stem cell transplantations. HLA-G also participates in the modulation of the immune response during cancerogenesis. The aim of this study was to assess HLA-G level in blood serum, the percentage of NK cells and monocytes with expression of receptors for HLA-G (ILT2, ILT4, KIR2DL4 and NKG2D) in patients who received allogeneic stem cell transplantations, and their influence on the occurrence of graft-versus-host reaction. The study included 32 patients with bone marrow diseases (acute leukemias, myelodysplastic syndrome, chronic myeloid leukemia, paroxysmal nocturnal hemoglobinuria) who received allogeneic stem cell transplantations. We assessed the expression of receptors ILT2, ILT4, KIR2DL4 and NKG2D on monocytes and NK cells, as well as the level of HLA-G in blood serum in patients before conditioning, in the transplant hematopoietic reconstitution period following allogeneic bone marrow stem cell transplantation. The percentage of NK cells with expression of KIR2DL4, ILT2 and ILT4 receptors was higher in patients with 0–I grade GVHD than in patients with II–IV grade GVHD. The percentage of monocytes with expression of ILT4 and ILT2 receptors was higher in patients with 0–I grade GVHD than in patients with II–IV grade GVHD. The level of HLA-G in patients’ blood serum was higher after the stem cell transplantation compared with the period before transplantation. HLA-G level and HLA-G receptors are related to intensity of GVHD and may play the role of a prognostic factor for the development of GVHD and the clinical course of this reaction.
引用
收藏
相关论文
共 81 条
  • [1] Hunt JS(2005)HLA-G and immune tolerance in pregnancy FASEB J 19 681-693
  • [2] Petroff MG(2012)The immunosuppressive molecule HLA-G and its clinical implications Crit Rev Clin Lab Sci 49 63-84
  • [3] McIntire RH(1994)A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4 J Immunol 153 5516-5524
  • [4] Ober C(1992)Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens Proc Natl Acad Sci USA 89 3947-3951
  • [5] Gonzales A(2001)HLA-G2, -G3 and –G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis J Immunol 166 5018-5026
  • [6] Rebmann V(2001)Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism Proc Natl Acad Sci USA 98 12150-12155
  • [7] LeMaoult J(2004)Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients Eur J Immunol 34 649-660
  • [8] Horn PA(2013)Molecular pathways: human leukocyte antigen G (HLA-G) Clin Cancer Res 19 5564-5571
  • [9] Carosella ED(2003)HLA-G in cancer: a way to turn off the immune system Semin Cancer Biol 13 325-336
  • [10] Alegre E(2003)HLA-G molecules: from maternal-fetal tolerance to tissue acceptance Adv Immunol 81 199-252
123456789